[ Price : $8.95]
A Tulane University researcher says FDAs use of pathologic complete response as a surrogate endpoint for rectal cancer treatments ...[ Price : $8.95]
FDA Oncology Center of Excellence director Richard Pazdur says the agency and its international partners are considering expanding...[ Price : $8.95]
FDA warns Boston, MA-based Whoop that it is illegally marketing an unapproved medical device that estimates blood pressure, despit...[ Price : $8.95]
A Phase 3 clinical trial evaluating Alexions anselamimab for light chain amyloidosis fails to meet its primary endpoint, but shows...[ Price : $8.95]
FDA releases a funding opportunity for natural history studies to advance product development in rare diseases and conditions.[ Price : $8.95]
FDA releases the form FDA-483 with seven observations from an inspection at Indias Natco Pharma.[ Price : $8.95]
FDA publishes a draft guidance on characterizing the effects of some oncology drugs when used in combination with other drugs.[ Price : $8.95]
FDA grants Zenith Epigenetics a fast-track designation for its ZEN-3694 and its use for treating metastatic or unresectable NUT ca...